Salih Şanlıoğlu

Akademik Profiller

1. 1
   Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospectsExpert Reviews in Molecular Medicine
   2025
2. 2
   Gene and cell therapy of human genetic diseases: Recent advances and future directionsJournal of Cellular and Molecular Medicine
   2024
3. 3
   Microglia cells treated with synthetic vasoactive intestinal peptide or transduced with LentiVIP protect neuronal cells against degeneration.The European journal of neuroscience
   2024
4. 4
   Generation of a Beta-Cell Transplant Animal Model of Diabetes Using CRISPR Technology.Advances in experimental medicine and biology
   2023
5. 5
   Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology.World journal of stem cells
   2021
6. 6
   Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for VaccinationHuman Gene Therapy
   2021
7. 7
   Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferationGene Therapy
   2021
8. 8
   Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced DiabetesMolecular Therapy
   2021
9. 9
   High-Grade Purification of Third-Generation HIV-Based Lentiviral Vectors by Anion Exchange Chromatography for Experimental Gene and Stem Cell Therapy Applications.Methods in molecular biology (Clifton, N.J.)
   2019
10. 10
    High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.Methods in molecular biology (Clifton, N.J.)
    2019

Yayın listesi ORCID kaydından alındı.